CN Stock MarketDetailed Quotes

600572 Zhejiang Conba Pharmaceutical

Watchlist
  • 4.70
  • +0.02+0.43%
Noon Break Dec 24 11:29 CST
12.08BMarket Cap24.87P/E (TTM)

Zhejiang Conba Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Conba Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.46B
--
+3.16%
EPS
--
0.04
--
--
Analyst Rating
Strong Buy

Dec 23, 2024

Zhejiang Conba Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q11.824B / 2.210B--
--2023/Q41.549B / 1.596B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q11.824B / 2.210B--
--2023/Q41.549B / 1.596B--
--------
--------
--------

Unlock Free Earnings Estimates

Zhejiang Conba Pharmaceutical Earnings Reports

  • Conn Bay Third Quarter 2024 Report

    Oct 29 12:00 ET

  • Zhejiang Conba Pharmaceutical 2024 Interim Report Full Text

    Aug 23 12:00 ET

  • Zhejiang Conba Pharmaceutical 2024 Interim Report Summary

    Aug 23 12:00 ET

  • Conn Bay 2024 First Quarter Report

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 23, 2024

    Strong Buy

    • Strong Buy

      73.33%

    • Buy

      26.67%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Ophthalmology
    Ophthalmology
    Intraday+1.01%
    The Concept of Old Age
    The Concept of Old Age
    Intraday+1.01%
    MSCI concept
    MSCI concept
    Intraday+0.80%